2012 Annual Meeting | Neuro Flash: Child Neurology

Date Friday 04/27/12

Time 06:30 AM - 08:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Neuro Flash

Director(s) Ann H. Tilton, MD, F�鶹��ýӳ��

Topic(s)

Learning Objectives Participants should be familiar with the differential diagnoses, the distinguishing characteristics, as well as the approach to therapy of these three often confusing and yet frequent disorders that occur in the care of children and young adults.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Interactive, Audience Participation

Program Evaluations

Event Timeline
06:30 AM - 07:15 AM		New Developments in Childhood Headache Kenneth J. Mack, MD, PhD, F�鶹��ýӳ��
06:30 AM - 08:00 AM		Break
07:15 AM - 08:00 AM		Treatment Update For Duchenne Muscular Dystrophy - Why the Gene Matters Anne M. Connolly, MD, F�鶹��ýӳ��

Faculty Disclosures
Ann H. Tilton, MD, F�鶹��ýӳ��	Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date.
Kenneth J. Mack, MD, PhD, F�鶹��ýӳ��	Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Mack has received publishing royalties from a publication relating to health care. Dr. Mack has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Justice, DVIC.
Anne M. Connolly, MD, F�鶹��ýӳ��	Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. Dr. Connolly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Connolly has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. The institution of Dr. Connolly has received research support from Muscular Dystrophy Association. The institution of Dr. Connolly has received research support from NIH.